Astrana Health (ASTH) Gains from Sales and Divestitures (2024 - 2025)
Astrana Health (ASTH) posted Gains from Sales and Divestitures of $363061.0 for Q4 2025, up 364.24% sequentially from $78206.0 in Q4 2024, and up 364.24% YoY from $78206.0 in Q4 2024.
Astrana Health (ASTH) Gains from Sales and Divestitures (2024 - 2025) Analysis & Trends
Astrana Health (ASTH) has 2 years of Gains from Sales and Divestitures data on file, last reported at $363061.0 in Q4 2025.
- Quarterly Gains from Sales and Divestitures rose 364.24% year-over-year to $363061.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $363061.0 (up 364.24% YoY) and the FY2025 annual result came in at $363061.0, up 364.24% from the prior year.
- Gains from Sales and Divestitures advanced to $363061.0 in Q4 2025 per ASTH's latest filing, from $78206.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $363061.0 in Q4 2025, with the low at $78206.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn |
| 10 | Astrana Health | 2.44 Mn | -461.02 Mn | 105.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 363,061.00 |
| Dec 31, 2025 | 363,061.00 |
| Dec 31, 2024 | 78,206.00 |
| Dec 31, 2024 | 78,206.00 |